United Therapeutics (UTHR) Inventory (2016 - 2025)
Historic Inventory for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $176.5 million.
- United Therapeutics' Inventory rose 2031.36% to $176.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.5 million, marking a year-over-year increase of 2031.36%. This contributed to the annual value of $157.9 million for FY2024, which is 4123.43% up from last year.
- Latest data reveals that United Therapeutics reported Inventory of $176.5 million as of Q3 2025, which was up 2031.36% from $169.2 million recorded in Q2 2025.
- United Therapeutics' 5-year Inventory high stood at $176.5 million for Q3 2025, and its period low was $88.2 million during Q1 2022.
- In the last 5 years, United Therapeutics' Inventory had a median value of $103.3 million in 2023 and averaged $117.8 million.
- As far as peak fluctuations go, United Therapeutics' Inventory tumbled by 589.45% in 2022, and later surged by 4123.43% in 2024.
- Over the past 5 years, United Therapeutics' Inventory (Quarter) stood at $93.8 million in 2021, then rose by 8.74% to $102.0 million in 2022, then increased by 9.61% to $111.8 million in 2023, then skyrocketed by 41.23% to $157.9 million in 2024, then increased by 11.78% to $176.5 million in 2025.
- Its Inventory stands at $176.5 million for Q3 2025, versus $169.2 million for Q2 2025 and $165.4 million for Q1 2025.